IPERIONX LIMITED (IPX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IPX

IPX - IPERIONX LIMITED

FNArena Sector : Industrial Metals
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: -0.07
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.52

15 Apr
2025

0.160

OPEN

$2.51

6.78%

HIGH

$2.59

2,702,092

LOW

$2.36

TARGET
$5.90 134.1% upside
OTHER COMPANIES IN THE SAME SECTOR
AIS . CHN . COB . DVP . JMS . OMH . WA1 .
FNARENA'S MARKET CONSENSUS FORECASTS
IPX: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx - 15.3 - 6.4 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

N/A

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 18/11 - (franking Ex-Di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-15.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx0.0 M
Book Value Per Share xxxxxxxxxxxxxxx29.9
Net Operating Cash Flow xxxxxxxxxxxxxxx-28.4 M
Net Profit Margin xxxxxxxxxxxxxxx-

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-61.87 %
Return on Invested Capital xxxxxxxxxxxxxxx-60.49 %
Return on Assets xxxxxxxxxxxxxxx-56.85 %
Return on Equity xxxxxxxxxxxxxxx-61.87 %
Return on Total Capital xxxxxxxxxxxxxxx-61.93 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-36.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx50 M
Price To Book Value xxxxxxxxxxxxxxx6.83

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx12.3 M
Capex % of Sales xxxxxxxxxxxxxxx-
Cost of Goods Sold xxxxxxxxxxxxxxx1 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx34 M
Research & Development xxxxxxxxxxxxxxx13 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

16/04/2025

1

Speculative Buy

$5.90

134.13%

Bell Potter notes IperionX ended the March quarter with US$66m cash, down from US$77m in December, and no debt.

Likely news flow ahead includes revision to installed capacity at the Titanium manufacturing campus in Virgin, expected in mid-2025, and the next phase of capital expansion that needs to be submitted to the US Department of Defense as part of funding arrangement.

Speculative Buy. Target unchanged at $5.90.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -6.40 cents.
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of 10.60 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxxxxxxxxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Petra Capital

10/04/2025

1

Buy

$6.75

167.86%

Petra Capital believes Iperionx is a beneficiary of tariffs imposed by the US, pointing to the strong share price performance of US-listed uranium companies.

Tariffs are a boost to US-made lithium via cost advantage and higher demand from original equipment manufacturers as they reassess supply chain.

One reason for underperformance would be the company is not generating revenue yet, but the upside risk on tariffs provides an attractive entry opportunity, the broker notes.

Buy. Target unchanged at $6.75.

FORECAST
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -2.30 cents.
Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.30 cents.

IPX STOCK CHART